JanetK.HortonMD
Radiation Oncology • Winston Salem, NCBreast Cancer
Assistant Professor, Radiation Oncology, Duke University School of Medicine
Dr. Horton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
S Hawthorne Rd
Winston Salem, NC 27157Phone+1 336-716-2255
Education & Training
University of North Carolina HospitalsResidency, Radiation Oncology, 2002 - 2006
Cone HealthInternship, Internal Medicine, 2001 - 2002
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2001
Certifications & Licensure
NC State Medical License 2002 - 2025- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Single Dose Partial Breast Radiotherapy Start of enrollment: 2010 Jul 28
- Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer Start of enrollment: 2012 Jan 01
- Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast Cancer Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- 51 citationsEvaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 TrialS.J. Chmura, Kathryn Winter, Clifford G. Robinson, Thomas M. Pisansky, Virginia F. Borges
JAMA Oncology. 2021-06-01 - 9 citationsPhase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast CancerRandall J. Kimple, Janet K. Horton, Chad A. Livasy, Janiel M. Shields, Julia Lawrence
The Oncologist. 2012-12-01 - 95 citationsBlocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radio...Omar M. Rahal, Adam R. Wolfe, Pijus K. Mandal, Richard A. Larson, S Tin
International Journal of Radiation Oncology, Biology, Physics. 2017-12-01
Press Mentions
Study Finds Stereotactic Body Radiotherapy Is Safe for Treating Patients with Multiple MetastasesApril 21st, 2021- 2017 Red Journal Conflict of Interest/PhotographsAugust 18th, 2017
Du Kanske Också GillarNovember 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
